512POsimertinib in advanced or metastatic non-small cell lung cancer patients with EGFR T790M mutation after treatment with EGFR-TKI: Interim analysis of China cohort from the single-arm, open-label, international, multi-center real-world ASTRIS study. (25th November 2018) - Zhou, Q; Zhang, H; Jiang, L; Shi, Y; Chen, Y; Yu, J; Zhou, C; He, Y; Hu, Y; Liang, Z-A; Pan, Y; Zhuo, W; et al.